Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
4
Bullish
5
Bearish
6
Neutral
8
Bullish
32
Bearish
1
Neutral
4
Bullish
27
Bearish
1
Neutral
4
Bullish
27
Bearish
1
Neutral
4
Bullish
27
Bearish
1
Neutral
4
Bullish
27
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
167.45 | 330 Cr | 18.50 | 3.23 | 0.00 | 17.47 | 17.02 | 8.62 | ||
110.30 | 250 Cr | 22.39 | 2.57 | 0.00 | 11.48 | 15.13 | 8.40 | ||
97.90 | 229 Cr | 68.59 | 2.22 | 0.00 | 2.75 | 4.05 | 2.88 | ||
107.15 | 223 Cr | 1485.53 | 3.71 | 0.00 | 0.13 | 1.06 | 0.18 | ||
6.57 | 104 Cr | 8.42 | 0.60 | 0.00 | 7.09 | 7.42 | 5.52 | ||
126.50 | 86 Cr | 17.35 | 3.53 | 0.00 | -12.02 | -1.25 | -4.92 | ||
59.75 | 82 Cr | 27.53 | 2.01 | 0.00 | 7.29 | 18.00 | 4.87 | ||
| Median: 7 Co. | — | 107.15 | 223 Cr | 22.39 | 2.57 | 0.00 | 7.09 | 7.42 | 4.87 |
Hannah Joseph Hospital Ltd (HANNAH) is currently trading at 112.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Hannah Joseph Hospital Limited is a multi-specialty tertiary care hospital headquartered in Madurai, Tamil Nadu, focused on neurosciences, trauma, cardiology and psychiatry, operating a centrally air-conditioned campus with 133 beds and a team of 70+ doctors providing advanced diagnostics and interventions including neuroradiology and cath lab services. Financially, Hannah Joseph Hospital reported revenue of INR 92.05 crore for FY26 with EBITDA of INR 24.96 crore and EBITDA margin of 27.12%, while PAT rose to INR 11.18 crore and PAT margin to 12.15%, reflecting steady margin expansion and improving profitability over the last three years. Operational metrics show meaningful improvement: average bed occupancy stabilized at 57% in FY26, ARPOB increased materially from INR 80 lakh in FY23 to INR 139 lakh in FY26, and Revenue/Bed/Day jumped to INR 38,000, indicating better revenue realization driven by case mix and higher-value specialties. Strategically, Hannah Joseph Hospital has acquired adjacent land for a purpose-built oncology campus and has adopted advanced BrainLab navigation and AI-powered DTI Fiber Tracking 3.0, positioning the hospital to expand into high-margin oncology services and strengthen its regional referral hub status. The company completed an IPO in January 2026 raising INR 42 crore, which management positions for capacity expansion and technology investments, leveraging awards and regional recognition to capture patients from neighbouring states and NRI markets such as Sri Lanka, Malaysia, Singapore and the Middle East.
Over the past 52 weeks, Hannah Joseph Hospital Ltd has traded between a low of ₹55.99 and a high of ₹128.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Hannah Joseph Hospital Ltd has a market capitalization of approximately 254.22. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Hannah Joseph Hospital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 254.22 Cr, Hannah Joseph Hospital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Hannah Joseph Hospital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Hannah Joseph Hospital Ltd is 22.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Hannah Joseph Hospital Limited is a multi-specialty tertiary care hospital headquartered in Madurai, Tamil Nadu, focused on neurosciences, trauma, cardiology and psychiatry, operating a centrally air-conditioned campus with 133 beds and a team of 70+ doctors providing advanced diagnostics and interventions including neuroradiology and cath lab services.
Financially, Hannah Joseph Hospital reported revenue of INR 92.05 crore for FY26 with EBITDA of INR 24.96 crore and EBITDA margin of 27.12%, while PAT rose to INR 11.18 crore and PAT margin to 12.15%, reflecting steady margin expansion and improving profitability over the last three years.
Operational metrics show meaningful improvement: average bed occupancy stabilized at 57% in FY26, ARPOB increased materially from INR 80 lakh in FY23 to INR 139 lakh in FY26, and Revenue/Bed/Day jumped to INR 38,000, indicating better revenue realization driven by case mix and higher-value specialties.
Strategically, Hannah Joseph Hospital has acquired adjacent land for a purpose-built oncology campus and has adopted advanced BrainLab navigation and AI-powered DTI Fiber Tracking 3.0, positioning the hospital to expand into high-margin oncology services and strengthen its regional referral hub status.
The company completed an IPO in January 2026 raising INR 42 crore, which management positions for capacity expansion and technology investments, leveraging awards and regional recognition to capture patients from neighbouring states and NRI markets such as Sri Lanka, Malaysia, Singapore and the Middle East.
Healthcare Services
Hospital
254 Cr
Low Risk
22.7
60.9
0.2
2.6
128.80
55.99
Sales CAGR
Profit CAGR
ROE
ROCE
